An updated breast cancer screening guideline from the American Cancer Society (ACS) recommends that women at average risk start regular annual mammography screening at age 45 and transition to screening every two years starting at age 55.

For high-risk patients who receive chemoradiation therapy for head and neck cancer, frequent follow-up appointments conducted by advance practice nurses (APN) in a clinical outpatient setting allowed for more intensive symptom management. This program resulted in fewer post-treatment emergency room visits and hospital admissions compared to historical outcomes, according to research presented at the American Society for Radiation Oncology’s (ASTRO’s) 57th annual meeting.

The American College of Radiology (ACR) spoke out against the U.S. Preventive Services Task Force’s (USPSTF) exclusion of computed tomography (CT) colonography from its most recent list of recommended exams for colorectal cancer screening, saying the decision could be a significant blow to efforts to raise colorectal cancer screening rates.

Siemens’ PETNET Solutions Inc., a wholly owned subsidiary of Siemens Healthcare, will formulate the VPAC1 molecular biomarker 64Cu TP-3805 exclusively for clinical trials for the biopharmaceutical firm NuView Life Sciences Inc., of Park City, Utah.